Bausch + Lomb borrows $400M in new term loans maturing May 2027

Bausch Health Companies Inc.

Bausch + Lomb added $400M term loans under its credit agreement; proceeds used to repay revolver and for corporate purposes.
Loans mature May 10, 2027, with quarterly amortization: 0.625% of principal for first 8 installments, then 1.875%.
Interest at base rate or term SOFR plus margin: 2.25% (base) or 3.25% (SOFR); other terms unchanged.
Bausch Health (BHC) filed the 8-K; the borrowing is at subsidiary Bausch + Lomb (BLCO).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.